
European Journal of Medicinal Chemistry p. 4862 - 4888 (2009)
Update date:2022-08-04
Topics:
Cloonan, Suzanne M.
Keating, John J.
Butler, Stephen G.
Knox, Andrew J.S.
Jorgensen, Anne M.
Peters, Guenther H.
Rai, Dilip
Corrigan, Desmond
Lloyd, David G.
Williams, D. Clive
Meegan, Mary J.
The discovery that some serotonin reuptake transporter (SERT) ligands have the potential to act as pro-apoptotic agents in the treatment of cancer adds greatly to their diverse pharmacological application. 4-Methylthioamphetamine (MTA) is a selective ligand for SERT over other monoamine transporters. In this study, a novel library of structurally diverse 4-MTA analogues were synthesised with or without N-alkyl and/or C-α methyl or ethyl groups so that their potential SERT-dependent antiproliferative activity could be assessed. Many of the compounds displayed SERT-binding activity as well as cytotoxic activity. While there was no direct correlation between these two effects, a number of derivatives displayed anti-tumour effects in lymphoma, leukaemia and breast cancer cell lines, showing further potential to be developed as possible chemotherapeutic agents.
View Morewebsite:http://www.afinechem.com
Contact:+86-571-85134551
Address:No. 206 Zhen Hua Road, Hangzhou 310030, Zhejiang, China
PharmaResources(Kaiyuan)CO,.Ltd
Contact:+86-21-50720028
Address:No.3, Beihuan Road, Economic Development District, Kaiyuan City, Tieling City, Liaoning Province, China 112300
Shanghai PotentPharm Science and Technology Co.,Ltd
Contact:86-021-51969655
Address:Unit B, Building 18, No.300, Chuantu Rd,Pudong District, Shanghai 201202, China
Contact:+86-571-86025531 / 86024803
Address:1218-24 Guangyin Mansion,42 Fengqi East Road
Shanghai Goyic Pharmaceutical&Chemical Co,. Ltd
Contact:+86-021-60275964
Address:No. 528 ruiqing road
Doi:10.1248/cpb.38.597
(1990)Doi:10.1021/jm2006047
(2011)Doi:10.1021/om2005113
(2011)Doi:10.1016/0022-328X(91)86287-Z
(1991)Doi:10.1007/s00044-011-9899-3
(2012)Doi:10.1021/jo00024a039
(1991)